Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (474)	3/28/1998 6:52:00 PM
From: Jim Mac	Read Replies (1) \| Respond to of 1754

FTC has no problem with Visx collecting procedure fees on its machines (FTC told Visx it's okay many months ago), and since the vast majority of Visx's procedure fees presently DO NOT go thru PPP, there's no real threat to Visx's future earnings. If FTC has a problem with a few patents, why hasn't the Patent and Trademark Office which issued them said anything about them for the past 6-8 years? Obviously there's really no problem there either. The only problem is with PPP, which is being dissolved anyway, since it costs more than its worth. Therefore, the FTC is merely going thru the motions of looking tough at the behest of a handful of disgruntled, greedy doctors and late-comer laser manufacturer(s). No big deal. This kind of lawsuit has been around for years, and it seems more than coincidental that FTC did this after Visx sued for dissolution of PPP.